On April 7, 2005, the Food and Drug Administration requested that Pfizer suspend sales of BEXTRA (also known as Valdecoxib) in the United States. Further, the FDA is requiring all prescription anti-inflammatory arthritis medicines to provide additional information about cardiovascular and gastrointestinal risks. The FDA is also asking all the manufacturers of over-the-counter NSAIDs to revise their labels to include more information on cardiovascular, gastrointestinal and skin risks.
The FDA’s requests were the result of the release of the results of a scientific study of 5,930 people, which presented at a meeting of the American Heart Association recently. That study found that patients who took Bextra were more than twice as likely to suffer heart attacks or stroke.
Bextra is indicated for the treatment of pain, tenderness and swelling caused by osteoarthritis and adult rheumatoid arthritis. Bextra lawsuits started to increase in late 2004 after a number of studies showed the cox-2 inhibitor may increase the incidence of heart attacks and strokes.
We have helped many clients who have suffered injury or lost a loved one because they used a prescription medication deemed to be safe. Discover more information about other personal injury and wrongful death services offered by Bailey & Galyen, from motor vehicle accidents and animal attacks to medical malpractice.
If you have suffered any health problems after taking this drug, please contact the Drug Litigation Lawyers at Bailey & Galyen immediately for a FREE, no obligation consultation and review of your legal rights. Our attorneys have helped numerous clients just like you who have had injuries caused by pharmaceuticals they were led to believe were safe.